This trial is testing a new drug for prostate cancer that is given as a shot.
3 Primary · 2 Secondary · Reporting Duration: Treatment
Experimental Treatment
100 Total Participants · 6 Treatment Groups
Primary Treatment: abiraterone decanoate · No Placebo Group · Phase 1 & 2
Age 18+ · Male Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: